infonews.co.nz | + Add Your News |
| NEWS PHOTOS PROFILES INDEX |
Pharmaceutical Management Agency of New Zealand is part of the New Zealand medicines system and work to improve people's access to medicine, and to promote their optimal use.
PHARMAC is welcoming the appointment of Dr Sisira Jayathissa to the chairmanship of PTAC, says Medical Director Dr Peter Moodie.
397 views
Funded treatment options for New Zealand’s most common form of cancer will take a step forward in August when PHARMAC begins funding gefitinib (Iressa), a targeted treatment for lung cancer.
842 views
PHARMAC will extend funding to a type of antibiotic that can be used to treat and prevent pertussis (whooping cough) in children under one.
730 views
PHARMAC’s consultation on the proposal to change to a sole supplier of blood glucose testing strips and meters has ended with over 3000 submissions received.
456 views
With less than a week remaining, PHARMAC is keen to hear the public’s views on its proposal to fund insulin pumps.
420 views
PHARMAC is funding two new targeted cancer medicines following an agreement with GlaxoSmithKline.
422 views
A surge in the medicines budget over the past three years, combined with PHARMAC’s savings programmes, has seen PHARMAC investing heavily in new medicines.
443 views
NAPIER — The IronMāori event in Napier on 3 December is serious competition but brings a serious health message too, says PHARMAC’s Māori health manager Marama Parore.
808 views
Papers released by PHARMAC today outline the careful consideration given before funding was approved for the new-generation anticoagulant drug dabigatran (Pradaxa).
453 views
Getting closer to district health boards, on whose behalf PHARMAC aims to spend $777 million this year, took on a new meaning today.
436 views
Cancer treatment has taken another step forward with PHARMAC recently approving wider funding for two cancer treatments.
410 views
PHARMAC is moving to a more permissive and streamlined system for assessing people seeking medicines that aren’t funded on the Pharmaceutical Schedule.
429 views
PHARMAC is funding two new treatments for the bone-thinning disease osteoporosis.
407 views
A New Zealand preventative health campaign which has significantly improved take-up of cholesterol lowering medication among Maori and Pacific Island males sets the bar for Australia to develop its own initiatives to achieve similar outcomes for Indigenous Australians.
751 views
PHARMAC is welcoming the reappointment of Waikato Hospital physician Dr Graham Mills to the Pharmacology and Therapeutics Advisory Committee (PTAC).
401 views
PHARMAC is funding an innovative form of anti-blood clotting treatment that will significantly change the way anticoagulation is managed in New Zealand.
463 views
Kiwis could be paying more for pharmaceuticals if the Trans Pacific Partnership (TPP) free trade negotiations are successful, the Green Party said today.
358 views
PHARMAC is enabling New Zealanders with multiple myeloma (MM) to benefit from early use of a new treatment, bortezomib (Velcade) as well as providing wider access to thalidomide, another treatment used for MM.
430 views
People with epilepsy will have a new funded treatment from 1 May, when PHARMAC begins funding for lacosamide (Vimpat).
421 views
PHARMAC will fund a new treatment for the sleep disorder narcolepsy from 1 May 2011.
437 views
Changes in access rules for funded special foods will see more prescribers able to supply funded special foods to patients.
415 views
PHARMAC is welcoming the appointment of three new members to the Pharmacology and Therapeutics Advisory Committee (PTAC).
563 views
Learning from past experience will serve PHARMAC well as it takes a greater role in purchasing hospital medicines, says Chief Executive Matthew Brougham.
470 views
Government drug funder PHARMAC will provide wider access to treatments for multiple sclerosis (MS), and fund new blood-thinning and antibiotic treatments following an agreement with Bayer New Zealand Limited.
415 views
PHARMAC is adding two further treatments for depression to the Pharmaceutical Schedule from 1 December 2010.
429 views
People with brain tumours are to have greater access to an expensive cancer drug from 1 December.
421 views
Patients with a form of kidney cancer will have a new treatment option as part of a multi-product agreement between PHARMAC and Pfizer.
506 views
A $40 million lift in pharmaceutical spending has led to a significant rise in the number of medicines available to New Zealanders, and the number of people receiving them.
455 views
PHARMAC has launched a new online tool that will give people a look inside PHARMAC’s evaluation of medicine funding applications.
496 views
Two newly funded medicines will help the fight against drug-resistant strains of the human immunodeficiency virus (HIV) in a multi-product deal that will also help fight infections in hospitals.
481 views
| NEWS PHOTOS PROFILES INDEX |